Summary
With increasing age of the population and improvement of diagnostic tools, the incidence of abdominal aortic aneurysms (AAA) has been rising steadily. Despite an improvement in operative and interventional treatment options, AAA is the cause of death in 1–3% of men over 65 years of age in industrial countries, mostly due to rupture [1]. Therefore, routine screening for AAA by ultrasonography has been postulated in the past: a 60 year old man with an abdominal aortic diameter of less than 3 cm has a life-time risk of developing AAA close to zero. However, routine screening has not been found to be cost effective. Despite of the results of two well-designed studies, the limits of AAA qualifying the patient for surgery or intervention in contrast to conservative treatment is still a matter of debate. The present review article summarizes the current knowledge of the pathology, incidence, risks, natural course as well as symptoms and current treatment strategies of AAA on the basis of the recent literature.
Similar content being viewed by others
References
Sakalihasan N, Limet R, Defawe OD (2005) Abdominal aortic aneurysm. Lancet 365:1577–1589
Multicentre Aneurysm Screening Study Group (2002) Multicentre aneurysm screening study (MASS): cost effectivenss analysis of screening for abdominal aortic aneurysm based on four year results from randomised controlled trial BMJ 325:1135–1138
National Hospital Discharge Survey Data (2002) Hyattsville, Md: National Center for Health Statistics
Isselbacher EM (2004) Diseases of the aorta. In: Braunwald E, Zipes DP, Libby P, Bonour RO (eds) Braunwald’s heart disease. Saunder Philadelphia, pp 1403–1404
Liddington MI, Healther BP (1992) The relationship aortic diameter and body habitus. Eur J Vasc Surg 6:89–92
Johnston KW, Rutherford RB, Tilson MD, Shah DM, Hollier L, Stanley JC (1991) Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg 13:452–458
Singh K, Bonaa KH, Jacobsen BK, Bjork L, Solberg S (2001) Prevalence and risk factors for abdominal aortic aneurysms in a population-based study: the Tromso Study. Am J Epidemiol 154:236–244
Liddington MI, Heather BP (1992) The relationship between aortic diameter and body habitus. Eur J Vasc Surg 6:89–92
Schumacher H, Eckstein HH, Kallinowski F, Allenberg JR (1996) Morphometry and classification in abdominal aortic aneurysms. J Endovasc Surg 4:39–44
Jonasson L, Holm J, Skalli O, Bondjiers G, Hansson GK (1986) Regional accumulations of T cells, marcorphages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6:131–138
Herron GS, Unemori E, Wong M, Rapp JH, Hibbs MH, Stoney RJ (1991) Connective tissue proteinases and inhibitors in abdominal aortic aneurysms: involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. Arterioscler Thromb 11:1667–1677
Homes DR, Liao S, Parks WC, Thompson RW (1995) Medial neovascularization in abdominal aortic aneurysms: a histopathologic marker of aneurismal degeneration with pathophysiological implications. J Vasc Surg 21:761–771
Shah PK (1997) Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation 96:2115–2117
Curci JA, Lee JK, Thompson RW (2001) Pathogenesis of abdominal aortic aneurysm. In: Ernst CB, Stanley JC (eds) Current Therapy in Vascular Surgery. Elsevier, Philadelphia, pp 199–206
MacSweeney STR, Powell JT, Greenhalgh RM (1994) Pathogenesis of abdominal aortic aneurysm. Br J Surg 81:935–941
Van der Vliet J A, Boll APM (1997) Abdominal aortic aneurysm. Lancet 349:863–866
Satta J, Juvonen T, Haukipuro K, Juvonen M, Kairaluoma MI (1995) Increased turnover of collagen in abdominal aortic aneurysms, demonstrated by measuring the concentration of the aminoterminal propeptide of type III procollagen in peripheral and aortal blood samples. J Vasc Surg 22:155–160
Huffman MD, Curci JA, Moore G, Kerns DB, Starcher BC, Thompson RW (2000) Functional importance of connective tissue repair during the development of experimental abdominal aortic aneurysms. Surgery 128:429–438
Dobrin PB, Mrkvicka R (1994) Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurysmal dilatation. Cardiovasc Surg 2:484–488
Carrell TW, Burnand KG, Wells GM, Clements JM, Smith A (2000) Stromelysin- 1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase- 3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 105:477–482
Defawe OD, Colige A, Lambert CA et al (2003) TIMP-2 and PAI-1 mRNA levels are lower in aneurysmal as compared to athero-occlusive abdominal aortas. Cardiovasc Res 60:205– 213
Rao SK, Reddy KV, Cohen JR (1996) Role of serine proteases in aneurysm development. Ann NY Acad Sci 800:131–137
Thompson RW, Parcs WC (1996) Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann NY Acad Sci 800:157–174
Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT (2002) Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 110:625–632
Shi G-P, Sukhova GK, Grubb A (1999) Cystatin C deficiency in human atherosclerosis and aortic aneurysms J Clin Invest 104:1191–1997
Zhao L, Moos PW, Gräbner R, Pedrono F, Fan J, Kaiser B, John N, Schmidt S, Spanbroek R, Lotzer K, Huang L, Cui J, Rader DJ, Evans JF, Hebnicht AJ, Funk CD (2004) The 5- lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nature 9:966–973
Lopez-Candales A, Holmes DR, Liao S, Scott MJ, Wickline SA, Thompson RW (1997) Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol 150:993–1007
Allaire E, Muscatelli-Groux B, Mandet C et al (2002) Paracrine effect of vascular smooth muscle cells in the prevention of aortic aneurysm formation. J Vasc Surg 36:1018–1026
Vorp DA, Lee PC, Wang DH et al (2001) Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and walk weakening. J Vasc Surg 43:291–299
Sakalihasan N, Delvenne P, Nusgens BV, Limet R, Lapiere CM (1996) Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg 24:127–133
Fontaine V, Jacob MP, Houard X et al (2002) Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol 161:1701–1710
Havanna KK, Eliason JL, Woodrum DT et al (2005) L-Selectin-mediated neutrophil recruitment in experimental rodent aneurysm formation. Circulation 112:241–247
Jones K, Powell J, Brown L, Greenhalgh R, Jormsjo S, Eriksson P (2002) Influence of 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene promotor on the incidence, growth and operative risk of abdominal aortic aneurysm. Eur. J Vasc Endovasc Surg 23:421–425
Boucher P, Gotthardt M, Li WP, Anderson RG, Herz J (2003) LRP: role in vascular wall integrity and protection from atherosclerosis. Science 300:329–332
Lederle, FA, Johnson GR, Wilson SE et al (2000) The aneurysm detection and mangement study screening program: validation cohort and final results. Arch Intern Med 160:1425–1430
Lindholdt JS, Vammen S, Juul S, Fasting H, Henneberg EW (2000) Optimal interval screening and surveillance of abdominal aortic aneurysms. Eur J Vasc Endovasc 20:369–373
Vardulaki KA, Walker NM, Day NE, Duffy W, Ashton HA, Scott RA (2000) Quantifying the risks of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm. Br J Surg 87:195–200
Pleumeekers HJCM, Hoes AW, van der Does E et al (1995) Aneurysms of the abdominal aorta in older adults; the Rotterdam study. Am J Epidemiol 142:1291–1299
Simoni G, Pastorino C, Perrone R, Ardia A, Gianrossi R, Decian F (1995) Screening for abdominal aortic aneurysms and associated risk factors in a general population. Eur J Vasc Endovasc Surg 10:207–210
Lederle FA, Johnson GR, Wilson SE (1997) Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detections and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med 126(6):441–449
Brown LC, Powell JT (1999) Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. UK Small Aneurysm Trial Participants. Ann Surg 230:289–296; discussion 296–297
Blanchard JF, Armenian HK, Friesen PP (2000) Risk factors for abdominal aortic aneurysm: results of a casecontrol study. Am J Epidemiol 151:575–583
Lindholt JS, Heegaard NH, Vammen S, Fasting H, Henneberg EW, Heickendorff L (2001) Smoking, but not lipids, lipoprotein(a) and antibodies against oxidised LDL, is correlated to the expansion of abdominal aortic aneuysms. Eur J Vasc Endovasc Surg 21:51–56
Wilmink TBM, Quick CRG, Day NE (1999) The association between cigarette smoking and abdominal aortic aneurysms. J Vasc Surg 30:1099–1105
Davies MJ (1998) Aortic aneurysm formation: lessons from human studies and experimental models. Circulation 98:193
Vardulaki KA, Prevost TC, Walker NM, Day NE, Wilmink AB, Quick CR, Ashton HA, Scott RA (1998) Growth rate and risk of rupture of abdominal aoric aneurysms. Br J Surg 85:1674–1680
Brady AR, Thompson SG, Fowkes FG, Greenhalgh RM, Powell JT (2004) Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation 110:16–21
MacSweeney STR, Ellis M, Worrell PC, Greenhalgh RM, Powell JT (1994) Smoking and growth rate of small abdominal aortic aneurysms. Lancet 344:651–652
Moran CS, McCann M, Karan M, Norman P, Ketheesan N, Golledge J (2005) Association of osteoprotegerin with human abdominal aortic aneurysm progression. Circulation 111(23):3119–3125
Newman AB, Shemanski L, Manolio TA et al (1999) Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 19:538–545
Gacko M, Chyczewski L (1997) Activity and localization of cathepsin B, D, and G in aortic aneurysm. Int Surg 82(4):398–402
Portik-Dobos V, Anstat MP, Hutchinson J et al (2002) Evidence for a matrix metalloproteinase induction/activation system in arterial vasculature and decreased synthesis and activity in diabetes. Diabetes 51:3036–3068
Mehard WB, Heiken JP, Sicard GA (1994) High-attenuating crescent in abdominal aortic aneurysm wall at CT: a sign of acute or impending rupture. Radiology 192:359–362
Siegel CL, Cohan RH, Korobkin M, Alpern MB, Courneya DL, Leder RA (1994) Abdominal aortic aneurysm morphology: CT features in patients with ruptured and nonruptured aneurysms. AJR Am J Roentgenol 163:1123–1129
Arita T, Matsunaga N, Takano K et al (1997) Abdominal aortic aneurysm: rupture associated with the high-attenuating crescent sign. Radiology 204:765–768
Sakalihasan N, Van Damme H, Gomez P et al (2002) Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA). Eur J Vasc Endovasc Surg 23:431–436
Elzouki AN, Ryden Ahlgren A, Lanne T, Sonesson B, Eriksson S (1999) Is there a relationship between abdominal aortic aneurysms and alpha1- antitrypsin deficiency (PiZ)? Eur J Vasc Endovasc Surg 17:149–154
Limet R, Sakalihasan N, Albert A (1991) Determination of the expansion rate and incidence of rupture of abdominal aortic aneurysms. J Vasc Surg 14):540–548
Muluk SC, Gertler JP, Brewster DC et al (1994) Presentations and patterns of aortic aneuryms in young patients. J Vasc Surg 20:880
Kiell CS, Ernst CB (1993) Advances in the management of abdominal aortic aneurysms. Dv Surg 26:73
Tang T, Wai-Leng C, Munday I, Gaunt M (2005) Ruptured abdominal aortic aneurysm. Lancet 365(9461):818
Abrurahma AF, Woodruff BA, Stuart SP, Lucente FC, Boland JP (1991) Early diagnosis and survival of ruptured abdominal aoric aneurysms. Am J Emerg Med 9(2):118–121
Parry DJ, Waterworth A, Kessel D, Robertson I, Berridge DC, Scott DJ (2001) Endovascular repair of an inflammatory abdominal aortic aneurysm complicated by aortoduodenal fistulation with an unusual presentation. J Vasc Surg 33:874–879
Kane JM, Meyer KA, Kozoll DD (1955) An anatomical approach to the problem of massive gastrointestinal hemorrhag. AMA Arch Surg 70:570–582
Hirst AE Jr, Affeldt J (1951) Abdominal aortic aneurysm with rupture into the duodenum; a report of eight cases. Gastroenterol 17:504–514
Lemos DW, Raffetto JD, Moore TC, Menzoian JO (2003) Primary aortoduodenal fistula: a case report and review of the literature. J Vasc Surg 37:686–689
Davis PM, Gloviczki P, Cherry KJ Jr et al (1998) Aorto-caval and ilio-iliac arteriovenous fistulae. Am J Surg 176:115–118
Lederle FA, Walker JM, Reinke DB (1988) Selective screening for abdominal aortic aneuryms with physical examination and ultrasound. Arch Intern Med 148:1753–1756
Beede SD, Ballard DJ, James EM, Ilstrup DM, Hallet JW Jr (1990) Positive predictive value of clinical suspicion of abdominal aortic aneurysm. Implications for efficient use of abdominal ultrasonography. Arch Intern Med 150(3):549–551
Lindholt JS, Vammen S, Juul S, Henneberg EW, Fasting H (1999) The validity of ultrasonographic scanning as screening method for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 17(6):472–775
Crow P, Shaw E, Earnshaw JJ, Poskitt KR, Whyman MR, Heather BP (2001) A single normal ultrasonographic scan at age 65 years rules out significant aneurysm disease for life in men. Br J Surg 88:941–944
Scott RAP, Vardulaki KA, Walker NM, Day NE, Duffy W, Ashton HA (2001) The longterm benefits of a single scan for abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Eur J Vasc Endovasc Surg 21:535–540
Frydman G, Walker PJ, Summers K et al (2003) The value of screening in siblings of patients with abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 26:396–400
Silence J, Lupu F, Collen D, Lijnen HR (2001) Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation. Atheroscler Thromb Vasc Biol 1440–1445
Powell JT, Greenhalgh RM (2003) Clinical practice. Small abdominal aortic aneurysms. N Engl J Med 348(19):1895–1901
The UK Small Aneurysm Trial Participants (1998) Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet 352:1649–1655
The United Kingdom Small Aneurysm Trial Participants (2002) Longterm outcomes of immediate repair compared with surveillance for small abdominal aortic aneurysm. N Engl J Med 346:1445–1452
Ashton HA, Buxton MJ, Day NE et al (2002) The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality on men: a randomised controlled trial. Lancet 360:1531–1539
Parodi JC, Palmaz JC, Barone HD (1991) Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg 5:491–499
Prinssen M, Verhoeven EL, Buth J et al (2004) A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med 351:1607–1618
Greenhalgh RM, Brown LC, Kwong GP, Powell JT, Thompson SG; EVAR trial participants (2004) Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operativ mortality results: randomied controlled trial. Lancet 364:843–848
Hallet JW Jr, Marshall DM, Petterson TM et al (1997) Graft-related complications after abdominal artic aneurysm repair: reassurance from a 36- year population-based experience. J Vasc Surg 25:277–284; discussion 285–286
Johnston KW (1994) Nonruptured abdominal aortic aneurysm: six-year follow-up results from the mulicenter prospective Canadian aneurysm study. J Vasc Surg 20:163–170
Lederle FA, Wilson ES, Johnson GR et al (2002) Immediate repair compared with surveillance of small aortic abdominal aneurysms. N Engl J Med 346:1437–1444
Greenhalgh RM, Brown LC, Kwong GP, Powell JT, Thompson SG; EVAR trial participants (2005) Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet 365:2179–2186
Blankensteijn JD, de Jong SECA, Prinsson M, van der Ham AC, Buth J, van Sterkenburg SMM, Verhagen HJM, Buskens E, Grobbee DE for the Dutch Randomised Endovascular Aneurysm Management (DREAM) (2005) Trial Group N Engl J Med 352:2398–2405
Greenhalgh RM, Brown LC, Kwong GP, Powell JT, Thompson SG; EVAR trial participants (2005) Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial. Lancet 365:2187–2192
Curci JA, Petrinec D, Liao S, Golub LM, Thompson RW (1998) Pharmacological suppression of experimental abdominal aortic aneurysms: a comparison of doxycycline and four chemically modified tetracyclines. J Vasc Surg 28:1082–1093
Bigatel DA, Elmore JR, Carey DJ, Cizmeci- Smith G, Franklin DP, Youkey JR (1999) The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms. J Vasc Surg 29:130–138; discussion 138–139
Moore G, Liao S, Curci JA et al (1999) Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamatebased matrix metalloproteinase inhibitor (RS 132908). J Vasc Surg 29:522–532
Takemoto M, Liao JK (2001) Pleiotropic effects of 3-hydroxy-3-methylglutary coenzyme A reductase inhibitors. Arterioscler Thromb Vasc Biol 21:1712–1719
Crisby M, Nordin-Fredriksson G, Sha PK, Yano J, Zhu J, Nilsson J (2001) Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103:926–933
Sposito AC, Chapman MJ (2002) Statin therapy in acute coronary syndromes; mechanistic insight into clinical benefit. Arterioscer Thromb Vasc Biol 22:1524–1534
Kwak B, Mulhaupt F, Myit S, Mach F (2000) Statins as a newly recognized type of immunomodulator. Nat Med 6:1399–1402
Kertai MD, Boersma E, Westerhout CM et al (2004) Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med 116:96–103
Nagashima H, Aoka Y, Sakomura Y et al (2002) A 3-hydroxy-3-methylglutaryl coenzyme. A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. J Vasc Surg 26:158–163
Gadowski GR, Pilcher DB, Ricci MA (1994) Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade. J Vasc Surg 19:727–731
Slaiby JM, Ricci MA, Gadowski GR, Hendley ED, Pilcher DB (1994) Expansion of aortic aneurysms is reduced by propanolol in a hypertensive rat model. J Vasc Surg 20:178–183
Nilsson J, Hansson GK, Shah PK (2005) Immunomodulation of atherosclerosis: implications for vaccine development. Arterioscler Thromb Vasc Biol 25:18–28
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zankl, A.R., Schumacher, H., Krumsdorf, U. et al. Pathology, natural history and treatment of abdominal aortic aneurysms. Clin Res Cardiol 96, 140–151 (2007). https://doi.org/10.1007/s00392-007-0472-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-007-0472-5